These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10418784)

  • 1. Lead-induced decrements in waiting behavior: involvement of D2-like dopamine receptors.
    Brockel BJ; Cory-Slechta DA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):423-34. PubMed ID: 10418784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level lead exposure modulates effects of quinpirole and eticlopride on response rates in a fixed-interval schedule.
    Areola OO; Jadhav AL
    Pharmacol Biochem Behav; 2001; 69(1-2):151-6. PubMed ID: 11420080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats.
    Frederick DL; Allen JD
    Pharmacol Biochem Behav; 1996 Apr; 53(4):759-64. PubMed ID: 8801575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dopamine agonists on fixed interval schedule-controlled behavior are selectively altered by low-level lead exposure.
    Cory-Slechta DA; Pokora MJ; Preston RA
    Neurotoxicol Teratol; 1996; 18(5):565-75. PubMed ID: 8888021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 antagonist during development decreases anxiety and infanticidal behavior in adult female prairie voles (Microtus ochrogaster).
    Hostetler CM; Harkey SL; Bales KL
    Behav Brain Res; 2010 Jun; 210(1):127-30. PubMed ID: 20152865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors.
    Self DW; Belluzzi JD; Kossuth S; Stein L
    Psychopharmacology (Berl); 1996 Feb; 123(4):303-6. PubMed ID: 8867867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
    Pokora MJ; Richfield EK; Cory-Slechta DA
    J Neurochem; 1996 Oct; 67(4):1540-50. PubMed ID: 8858938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.
    Wilkerson A; Levin ED
    Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
    Platt DM; Rodefer JS; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
    Izzo E; Orsini C; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior.
    Boulougouris V; Castañé A; Robbins TW
    Psychopharmacology (Berl); 2009 Mar; 202(4):611-20. PubMed ID: 18836703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.